Hazelwood, MO, United States of America

Joel McClenaghan

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Hazelwood, MO (US) (2019 - 2021)
  • Webster Groves, MO (US) (2021)

Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Mind of Joel McClenaghan: A Journey Through His Patents

Introduction

Joel McClenaghan is a notable inventor based in Hazelwood, Missouri, who has made significant contributions to the field of pharmaceuticals. With a total of four patents to his name, he demonstrates a strong commitment to innovation and scientific improvement, particularly in the area of drug formulation.

Latest Patents

Among his latest inventions, Joel has developed two groundbreaking processes:

1. **Preparation of Sufentanil Citrate and Sufentanil Base** - This patent outlines processes for forming sufentanil citrate from sufentanil base, utilizing both polar non-aqueous solvents and aqueous environments.

2. **Process for Preparing Acylated Amphetamine Derivatives** - This work focuses on innovative methods for preparing acetylated amphetamine derivatives, specifically detailing the preparation of lysine-amphetamine dimesylate from amphetamine salts.

Career Highlights

Joel's career is marked by his role at Specgx LLC, where he has continued to refine his research and development skills. His experience in the pharmaceutical industry enables him to play a vital role in enhancing drug formulations and therapeutic options.

Collaborations

Throughout his career, Joel has had the pleasure of collaborating with esteemed colleagues, including Brian Orr and George Helmut Klemm. These partnerships have fostered a rich environment for innovation and propelled advancements within their collective projects.

Conclusion

Joel McClenaghan's inventive spirit and dedication to research exemplify the impact of innovation in pharmaceuticals. As he continues to advance his work at Specgx LLC, his contributions to the field promise to influence future developments and enhance therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…